Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Catalin Adrian Buzea, Lorena Dima, Christoph U. Correll & Peter Manu. (2022) Drug–drug interactions involving antipsychotics and antihypertensives. Expert Opinion on Drug Metabolism & Toxicology 18:4, pages 285-298.
Read now
Read now
Ofelia Loani Elvir-Lazo, Paul F White, Hillenn Cruz Eng, Firuz Yumul, Raissa Chua & Roya Yumul. (2021) Impact of chronic medications in the perioperative period: mechanisms of action and adverse drug effects (Part I). Postgraduate Medicine 133:8, pages 939-952.
Read now
Read now
Amelework Eshetu Melka, Eyasu Makonnen, Asfaw Debella, Netsanet Fekadu & Bekesho Geleta. (2016) Diuretic activity of the aqueous crude extract and solvent fractions of the leaves of Thymus serrulatus in mice. Journal of Experimental Pharmacology 8, pages 61-67.
Read now
Read now
Abdul Ahad, Abdullah Mohammed Al-Mohizea, Fahad Ibrahim Al-Jenoobi & Mohd. Aqil. (2016) Transdermal delivery of angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs) and others for management of hypertension. Drug Delivery 23:2, pages 579-590.
Read now
Read now
Articles from other publishers (52)
Michel Azizi, Aurélien Lorthioir & Laurence Amar. 2024. Hypertension. Hypertension
542
555
.
Shradha Lakhera, Kamal Devlal & Meenakshi Rana. (2023) Utilization of methyclothiazide adsorbed with malonamide for quantum chemical applications: A DFT and DFT-D2/D3 studies. Optik 295, pages 171485.
Crossref
Crossref
Monica Butnariu, Deborah Fratantonio, Jesús Herrera-Bravo, Sonal Sukreet, Miquel Martorell, Garsiya Ekaterina Robertovna, Francisco Les, Víctor López, Manoj Kumar, Marius Pentea, Ioan Sarac, Alexandra Becherescu, Natália Cruz-Martins, William N. Setzer, Marcello Iriti, Hafiz Ansar Rasul Suleria & Javad Sharifi-Rad. (2023) Plant-food-derived Bioactives in Managing Hypertension: From Current
Findings to Upcoming Effective Pharmacotherapies. Current Topics in Medicinal Chemistry 23:8, pages 589-617.
Crossref
Crossref
Roberto Minutolo, Luca De Nicola, Francesca Mallamaci & Carmine Zoccali. (2023) Thiazide diuretics are back in CKD: the case of chlorthalidone. Clinical Kidney Journal 16:1, pages 41-51.
Crossref
Crossref
Wafaa Almosallam, Abeer A Aljoujou, Helen Rushdi Ayoubi & Hasan Alzoubi. (2023) Evaluation of the Effect of Antihypertensive Drugs on the Values of Dental Pulp Oxygen Saturation in Hypertension Patients: A Case-Control Study. Cureus.
Crossref
Crossref
Raja Chakraverty, Kalyan Samanta, Pallab Mandal & Samit Karmakar. 2023. How Synthetic Drugs Work. How Synthetic Drugs Work
369
390
.
Elena Kutumova, Ilya Kiselev, Ruslan Sharipov, Galina Lifshits & Fedor Kolpakov. (2022) Mathematical modeling of antihypertensive therapy. Frontiers in Physiology 13.
Crossref
Crossref
Gargi Sharma Priamvada, Divya Sharma Divyadarshini & Raven Voora. (2022) Use of Thiazides to Treat Hypertension and Advanced CKD. Current Cardiology Reports.
Crossref
Crossref
Ivan Velat, Željko Bušić & Viktor Čulić. (2022) Clinical predictors of hyponatremia in patients with heart failure according to severity of chronic kidney disease. Wiener klinische Wochenschrift 134:17-18, pages 636-645.
Crossref
Crossref
Yajun Liang, Yang Zhao, Kristina Johnell, Christian Rausch, Lucie Laflamme & Jette Möller. (2022) Newly initiated cardiovascular medication and short-term risk of unintentional poisoning among Swedish middle-aged and older adults: A national register-based case-crossover study. Biomedicine & Pharmacotherapy 151, pages 113152.
Crossref
Crossref
J.M. Llamas-Molina, F.J. Navarro-Triviño & R. Ruiz-Villaverde. (2022) [Translated article] What Dermatologists Should Know About Thiazides. Actas Dermo-Sifiliográficas 113:5, pages T498-T504.
Crossref
Crossref
J.M. Llamas-Molina, F.J. Navarro-Triviño & R. Ruiz-Villaverde. (2022) Tiazidas: lo que el dermatólogo debería saber. Actas Dermo-Sifiliográficas 113:5, pages 498-504.
Crossref
Crossref
Seyed Mehrdad Hamrahian. 2022. Approaches to Chronic Kidney Disease. Approaches to Chronic Kidney Disease
281
295
.
Simona Katrnošková, Jana Gregorová & Ivan Peychl. (2021) Long-term pharmacotherapy of the primary hypertension in children. Pediatrie pro praxi 22:6, pages 393-398.
Crossref
Crossref
David Mondaca-Ruff, Patricio Araos, Cristián E. Yañez, Ulises F. Novoa, Italo G. Mora, María Paz Ocaranza & Jorge E. Jalil. (2021) Hydrochlorothiazide Reduces Cardiac Hypertrophy, Fibrosis and Rho-Kinase Activation in DOCA-Salt Induced Hypertension. Journal of Cardiovascular Pharmacology and Therapeutics, pages 107424842110531.
Crossref
Crossref
Vishnu Priya Pulipati, Jon W. Mares & George L. Bakris. (2021) Optimizing Blood Pressure Control Without Adding Anti-Hypertensive Medications. The American Journal of Medicine 134:10, pages 1195-1198.
Crossref
Crossref
Jinlong Jiang, Fa-Xiang Ding, Xiaoyan Zhou, Thomas J. Bateman, Shuzhi Dong, Xin Gu, Reynalda Keh deJesus, Barbara Pio, Haifeng Tang, Harry R. Chobanian, Dorothy Levorse, Mengwei Hu, Brande Thomas-Fowlkes, Michael Margulis, Martin Koehler, Adam Weinglass, Jack Gibson, Kevin Houle, Joel Yudkovitz, Caryn Hampton, Lee-Yuh Pai, Koppara Samuel, Timothy Cutarelli, Kathleen Sullivan, Emma R. Parmee, Ian Davies & Alexander Pasternak. (2021) Discovery of MK-8153, a Potent and Selective ROMK Inhibitor and Novel Diuretic/Natriuretic. Journal of Medicinal Chemistry 64:11, pages 7691-7701.
Crossref
Crossref
Rosalie A. Scholtes, Michaël J. B. Baar, Megan D. Kok, Petter Bjornstad, David Z. I. Cherney, Jaap A. Joles & Daniël H. Raalte. (2021) Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors. Nephrology 26:5, pages 377-390.
Crossref
Crossref
Vasyl Y. Hys, Demyd S. Milokhov, Tetiana Ye. Keda, Iryna V. Omelchenko, Irina S. Konovalova, Svitlana V. Shishkina & Yulian M. Volovenko. (2021) Efficient synthesis of seven-membered Aza-sultams: Heterofused amino-1,2,4-thiadiazepine dioxides. Tetrahedron 88, pages 132149.
Crossref
Crossref
Kevin S. Fay & Debbie L. Cohen. (2021) Resistant Hypertension in People With CKD: A Review. American Journal of Kidney Diseases 77:1, pages 110-121.
Crossref
Crossref
Adriana Marton, Tatsuroh Kaneko, Jean-Paul Kovalik, Atsutaka Yasui, Akira Nishiyama, Kento Kitada & Jens Titze. (2020) Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation. Nature Reviews Nephrology 17:1, pages 65-77.
Crossref
Crossref
Reinhold Kreutz & Engi Abd el-Hady Algharably. 2021. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology
165
174
.
A. I. Kochetkov. (2020) Thiazide and Thiazide-like Diuretics in the Treatment of Arterial Hypertension: are there Any Differences?. Rational Pharmacotherapy in Cardiology 16:6, pages 994-1001.
Crossref
Crossref
Dan-feng Li, Yu-lu Gao, Hong-chao Liu, Xiao-chen Huang, Rui-fang Zhu & Chang-tai Zhu. (2020) Use of thiazide diuretics for the prevention of recurrent kidney calculi: a systematic review and meta-analysis. Journal of Translational Medicine 18:1.
Crossref
Crossref
Anna C. van der Burgh, Sadaf Oliai Araghi, M. Carola Zillikens, Fjorda Koromani, Fernando Rivadeneira, Nathalie van der Velde, Ewout J. Hoorn, André G. Uitterlinden, M. Arfan Ikram & Bruno H. Stricker. (2020) The impact of thiazide diuretics on bone mineral density and the trabecular bone score: the Rotterdam Study. Bone 138, pages 115475.
Crossref
Crossref
Camile Cecconi Cechinel-Zanchett, Luísa Nathália Bolda Mariano, Thaise Boeing, Juliana de Carvalho da Costa, Luísa Mota Da Silva, Jairo K. Bastos, Valdir Cechinel-Filho & Priscila de Souza. (2020)
Diuretic and Renal Protective Effect of Kaempferol 3-
O
-Alpha-
l
-rhamnoside (Afzelin) in Normotensive and Hypertensive Rats
. Journal of Natural Products 83:6, pages 1980-1989.
Crossref
Crossref
Rutai Hui. 2020. Coronary Artery Disease: Therapeutics and Drug Discovery. Coronary Artery Disease: Therapeutics and Drug Discovery
149
268
.
Reinhold Kreutz & Engi Abd El-Hady Algharably. 2020. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology
1
10
.
Jia Yin, David J. Wagner, Bhagwat Prasad, Nina Isoherranen, Kenneth E. Thummel & Joanne Wang. (2019) Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K. American Journal of Physiology-Renal Physiology 317:4, pages F805-F814.
Crossref
Crossref
Reinhold Kreutz, Engi Abdel Hady Algharably & Antonios Douros. (2019) Reviewing the effects of thiazide and thiazide-like diuretics as photosensitizing drugs on the risk of skin cancer. Journal of Hypertension 37:10, pages 1950-1958.
Crossref
Crossref
Robert M. Rapoport & Manoocher Soleimani. (2019) Mechanism of Thiazide Diuretic Arterial Pressure Reduction: The Search Continues. Frontiers in Pharmacology 10.
Crossref
Crossref
Lennart Tonneijck, Marcel H. A. Muskiet, Charles J. Blijdorp, Mark M. Smits, Jos W. Twisk, Mark H. H. Kramer, A. H. J. Danser, Michaela Diamant, Jaap A. Joles, Ewout J. Hoorn & Daniël H. van Raalte. (2019) Renal tubular effects of prolonged therapy with the GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes mellitus. American Journal of Physiology-Renal Physiology 316:2, pages F231-F240.
Crossref
Crossref
Tatiana V. Macfarlane, Filippo Pigazzani, Robert W.V. Flynn & Thomas M. MacDonald. (2018)
The effect of indapamide
vs
. bendroflumethiazide for primary hypertension: a systematic review
. British Journal of Clinical Pharmacology 85:2, pages 285-303.
Crossref
Crossref
A A Seyerle, C M Sitlani, R Noordam, S M Gogarten, J Li, X Li, D S Evans, F Sun, M A Laaksonen, A Isaacs, K Kristiansson, H M Highland, J D Stewart, T B Harris, S Trompet, J C Bis, G M Peloso, J A Brody, L Broer, E L Busch, Q Duan, A M Stilp, C J O'Donnell, P W Macfarlane, J S Floyd, J A Kors, H J Lin, R Li-Gao, T Sofer, R Méndez-Giráldez, S R Cummings, S R Heckbert, A Hofman, I Ford, Y Li, L J Launer, K Porthan, C Newton-Cheh, M D Napier, K F Kerr, A P Reiner, K M Rice, J Roach, B M Buckley, E Z Soliman, R de Mutsert, N Sotoodehnia, A G Uitterlinden, K E North, C R Lee, V Gudnason, T Stürmer, F R Rosendaal, K D Taylor, K L Wiggins, J G Wilson, Y-DI Chen, R C Kaplan, K Wilhelmsen, L A Cupples, V Salomaa, C van Duijn, J W Jukema, Y Liu, D O Mook-Kanamori, L A Lange, R S Vasan, A V Smith, B H Stricker, C C Laurie, J I Rotter, E A Whitsel, B M Psaty & C L Avery. (2017) Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology. The Pharmacogenomics Journal 18:2, pages 215-226.
Crossref
Crossref
André J. Scheen. (2018) Type 2 Diabetes and Thiazide Diuretics. Current Diabetes Reports 18:2.
Crossref
Crossref
Guillaume Bobrie, Laurence Amar, Anne-Laure Faucon, Anne-Marie Madjalian & Michel Azizi. 2018. Hypertension: A Companion to Braunwald's Heart Disease. Hypertension: A Companion to Braunwald's Heart Disease
398
408
.
S Wang, J Li, X Zhou, K Liu, X Zhang, Q Meng, R Shi, D Shi & X Chen. (2017) Comparison between the effects of hydrochlorothiazide and indapamide on the kidney in hypertensive patients inadequately controlled with losartan. Journal of Human Hypertension 31:12, pages 848-854.
Crossref
Crossref
Seyed Mehrdad Hamrahian. (2017) Management of Hypertension in Patients with Chronic Kidney Disease. Current Hypertension Reports 19:5.
Crossref
Crossref
Harry R. Chobanian, Yan Guo, Barbara Pio, Haifeng Tang, Nardos Teumelsan, Matthew Clements, Jessica Frie, Ronald Ferguson, Zach Guo, Brande S. Thomas-Fowlkes, John P. Felix, Jessica Liu, Martin Kohler, Birgit Priest, Caryn Hampton, Lee-Yuh Pai, Aaron Corona, Joseph Metzger, Vincent Tong, Elizabeth M. Joshi, Ling Xu, Karen Owens, Kevin Maloney, Kathleen Sullivan & Alexander Pasternak. (2017) The design and synthesis of novel spirocyclic heterocyclic sulfone ROMK inhibitors as diuretics. Bioorganic & Medicinal Chemistry Letters 27:4, pages 1109-1114.
Crossref
Crossref
Silvia Dossena, Emanuele Bernardinelli, Alok K. Sharma, Seth L. Alper & Markus Paulmichl. 2017. The Role of Pendrin in Health and Disease. The Role of Pendrin in Health and Disease
187
220
.
Yuping Zhu, Reynalda K. de Jesus, Haifeng Tang, Shawn P. Walsh, Jinlong Jiang, Xin Gu, Nardos Teumelsan, Aurash Shahripour, Barbara Pio, Fa-Xiang Ding, Sookhee Ha, Birgit T. Priest, Andrew M. Swensen, Magdalena Alonso-Galicia, John P. Felix, Richard M. Brochu, Timothy Bailey, Brande Thomas-Fowlkes, Xiaoyan Zhou, Lee-Yuh Pai, Caryn Hampton, Melba Hernandez, Karen Owens, Juliann Ehrhart, Sophie Roy, Gregory J. Kaczorowski, Lihu Yang, Emma R. Parmee, Kathleen Sullivan, Maria L. Garcia & Alexander Pasternak. (2016) Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold. Bioorganic & Medicinal Chemistry Letters 26:23, pages 5695-5702.
Crossref
Crossref
Douglas L. Blowey. (2016) Diuretics in the treatment of hypertension. Pediatric Nephrology 31:12, pages 2223-2233.
Crossref
Crossref
A.J. Scheen. (2016) Reappraisal of the diuretic effect of empagliflozin in the EMPA-REG OUTCOME trial: Comparison with classic diuretics. Diabetes & Metabolism 42:4, pages 224-233.
Crossref
Crossref
Gwen Hughes. (2016) Friendly pharmacodynamics: A simple introduction. Nurse Prescribing 14:1, pages 34-43.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
317
327
.
Seyed Mehrdad Hamrahian & Bonita Falkner. 2017. Hypertension: from basic research to clinical practice. Hypertension: from basic research to clinical practice
307
325
.
Patrick Rossignol, Ziad A Massy, Michel Azizi, George Bakris, Eberhard Ritz, Adrian Covic, David Goldsmith, Gunnar H Heine, Kitty J Jager, Mehmet Kanbay, Francesca Mallamaci, Alberto Ortiz, Raymond Vanholder, Andrzej Wiecek, Carmine Zoccali, Gérard Michel London, Bénédicte Stengel & Denis Fouque. (2015) The double challenge of resistant hypertension and chronic kidney disease. The Lancet 386:10003, pages 1588-1598.
Crossref
Crossref
Thiruvinvamalai S. Dharmarajan & Lekshmi Dharmarajan. (2015) Tolerability of Antihypertensive Medications in Older Adults. Drugs & Aging 32:10, pages 773-796.
Crossref
Crossref
Shawn P. Walsh, Aurash Shahripour, Haifeng Tang, Nardos Teumelsan, Jessica Frie, Yuping Zhu, Birgit T. Priest, Andrew M. Swensen, Jessica Liu, Michael Margulis, Richard Visconti, Adam Weinglass, John P. Felix, Richard M. Brochu, Timothy Bailey, Brande Thomas-Fowlkes, Magdalena Alonso-Galicia, Xiaoyan Zhou, Lee-Yuh Pai, Aaron Corona, Caryn Hampton, Melba Hernandez, Ross Bentley, Jing Chen, Kashmira Shah, Joseph Metzger, Michael Forrest, Karen Owens, Vincent Tong, Sookhee Ha, Sophie Roy, Gregory J. Kaczorowski, Lihu Yang, Emma Parmee, Maria L. Garcia, Kathleen Sullivan & Alexander Pasternak. (2015) Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation. ACS Medicinal Chemistry Letters 6:7, pages 747-752.
Crossref
Crossref
Linghong Wang, Chao Dong, Ya-Guang Xi & Xiulan Su. (2015) Thiazide-sensitive Na<sup>+</sup>–Cl<sup>−</sup> cotransporter: genetic polymorphisms and human diseases. Acta Biochimica et Biophysica Sinica 47:5, pages 325-334.
Crossref
Crossref
Sophia N Verouti, Emilie Boscardin, Edith Hummler & Simona Frateschi. (2015) Regulation of blood pressure and renal function by NCC and ENaC: lessons from genetically engineered mice. Current Opinion in Pharmacology 21, pages 60-72.
Crossref
Crossref
R.D. FeldmanY. HussainL.M. Kuyper, F.A. McAlister, R.S. Padwal & S.W. Tobe. (2015) Intraclass Differences Among Antihypertensive Drugs. Annual Review of Pharmacology and Toxicology 55:1, pages 333-352.
Crossref
Crossref